Clinical Trials in Salt Lake City

Showing 2121-2140 of 7,997 trials

First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

NCT05759949

This is a Phase 1, first-in-human, open-label study designed to evaluate the maximum tolerated dose (MTD), recommended phase 2 dose (RP2D), safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of RLY-5836 in advanced solid tumors in participants harboring a PIK3CA mutation in blood and/or tumor per local assessment. The study consists of 2 parts, a dose escalation (Part 1) and a dose expansion (Part 2).

PIK3CA MutationSolid Tumor, AdultHER2-negative Breast Cancer+5 more

Relay Therapeutics, Inc.41 participantsStarted Mar 2023

Orlando, Florida, United States • Indianapolis, Indiana, United States • Boston, Massachusetts, United States +4 more locations

Active Not Recruiting< 1 mile

KidneyCare Cohort Study (KCC-S)

NCT06898632

This research study aims to learn how lifestyle factors (e.g., obesity) impact the risk of developing kidney cancer and impact survival after nephrectomy (removal of a kidney). The study team's long-term goals are to learn: 1) How to improve treatment success in future patients by tailoring therapies to each patient's unique biology; and 2) What future patients can do to improve their health after diagnosis. To this end, the study team will collect samples (such as blood and extra tissue from surgery) from patients and store and test these samples. The study team also asks patients about their health behaviors (e.g., diet and physical activity) and well-being before their diagnosis and afterwards by filling out questionnaires.

Kidney Cancer

University of Utah161 participantsStarted Mar 2021

Salt Lake City, Utah, United States

First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

KidneyCare Cohort Study (KCC-S)

Find Trials by Condition in Salt Lake City

VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib

Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

7-week Study With CT-155 in People With Schizophrenia

Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)

A Study of IMR-687 in Subjects With Sickle Cell Disease

Measurements of CSF Shunts and Off-Shunt Locations With Wireless Thermal Anisotropy Measurement Devices

Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

Natural Versus Programmed Frozen Embryo Transfer (NatPro)

A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation